experiment 640 words
Contents

Gap Junction Dysfunction Validation in Parkinson's Disease

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (4)

Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.68
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.57
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.57
Gap Junction Hemichannel Modulation for Controlled Mitochond
Score: 0.36

Related Analyses (13)

Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed

Related Experiments (30)

Levodopa-Induced Dyskinesias Mechanism — Experiment Design
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40

Knowledge Graph (8 edges)

Connexin43 mediates Gap Junctions
Gap Junction Signalling involved_in Ovarian Stroma Support
GJA1-20k involved_in Gap Junction Formation
Gap26 inhibits GJA1
Gap26 associated_with Cerebral Infarct Volume
Gap26 associated_with Functional Recovery
Gap26 inhibits Astrogliosis
Gap26 interacts_with GJA1

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.